Women reveal the reasons they reject a preventive drug for breast cancer

Only around a fifth of women at higher risk of developing breast cancer think they need to take a drug proven to help prevent the disease, according to new research funded by Cancer Research UK and published today (Monday) in Clinical Breast Cancer.

Around 72% said they were worried about the long-term effects of tamoxifen and 57% believed that the would give them unpleasant side-effects.

The researchers, led by a team from the University of Leeds, asked more than 400 healthy women at a higher-risk of , from 20 centres across England, whether they thought they needed to take tamoxifen and their concerns about medication.

They discovered that almost a third (29%) of the women thought doctors prescribed too many medicines, and more than a third (35%) thought doctors would prescribe fewer drugs if they had more time. Around a quarter (24%) of the women had experienced bad reactions to medicines in the past.

Almost a quarter (24%) of the women thought people on medication should take regular breaks from the drugs; 23% said they were very sensitive to medicines and 17% believed natural remedies were safer than medicines.

In a follow-up questionnaire, answered by 250 of the women, researchers found that fewer than 15 per cent were taking tamoxifen despite having discussed preventive therapy with a healthcare professional. Women who believed the was less necessary and had more concerns about its use were less likely to be taking tamoxifen at follow-up.

Lead author Dr. Samuel Smith, from the University of Leeds, said: "Women in our study were rightfully considering the potential harms and benefits of using preventive therapy. But some beliefs about the use of medicine were very negative. This appears to be putting some women off tamoxifen, despite its proven ability to help prevent in the long term.

"We need to make sure health care professionals are adequately equipped to discuss the potential benefits and harms of preventive treatment with their patients so that women are well informed before deciding whether or not to take a drug."

Dr. Julie Sharp, Cancer Research UK's head of , said: "It's understandable that women considering taking a new medicine might have some concerns and that, for some, it won't be the right option. There are some potential side effects with , and other medications that can help prevent cancer, but it's vital that they have all the information, so they can make the best choice for them. If in this situation have any questions or want more information, they can visit our website or call our cancer nurses for a chat.


Explore further

Six in seven women at high risk of breast cancer shun tamoxifen as a preventative measure

More information: Rachael Jane Thorneloe et al, Beliefs About Medication and Uptake of Preventive Therapy in Women at Increased Risk of Breast Cancer: Results From a Multicenter Prospective Study, Clinical Breast Cancer (2018). DOI: 10.1016/j.clbc.2018.10.008
Provided by Cancer Research UK
Citation: Women reveal the reasons they reject a preventive drug for breast cancer (2018, December 3) retrieved 16 November 2019 from https://medicalxpress.com/news/2018-12-women-reveal-drug-breast-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
8 shares

Feedback to editors

User comments